AstraZeneca opens new development operations centre in Bengaluru
Bengaluru: Drug firm AstraZeneca Thursday said it has opened a new development operations centre in Bengaluru to support the expansion of its clinical research footprint in India.
"The development operations centre will employ over 30 clinical research experts that handle over 20 studies in 150 sites across India," AstraZeneca said in a statement.
This expansion will focus on managing studies in India to not only support the global clinical drug development, but also the local business with clinical data and evidence, it added.
"Because of the excellent skills of Indian clinical research experts and the improvement of regulations and approval timelines, we are pleased to expand our operations and continue to lead clinical research in India," AstraZeneca Development Operations (Site Management and Monitoring), Asia, Middle East & Africa (AMEA) Senior Regional Director Melissa Grady said.
The unit will support the development of AstraZeneca's medicines, hosting clinical trial experts focused on the company's core therapeutic areas - oncology, cardiovascular, renal and metabolism, as well as respiratory, the statement said.
Read Also: AstraZeneca shows cardiovascular safety for roxadustat in global Phase III trials
Headquartered at Cambridge UK, AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at email@example.com. Check out more about our bureau/team here